Skip to main content
    P

    Precigen Inc (PGEN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.20
    -0.16 (-2.18%)

    Market Cap: $2.62B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    44%(17/39)
    Avg Surprise
    -55.28%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.08
    Range$0.05 - $0.14
    4 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.00+2563.6%
    60d ago$-0.00+2563.6%
    30d ago$0.08+3.7%
    7d ago$0.08+3.7%
    Current$0.08
    Revenue Consensus
    $72M
    Range$60M - $87M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.19
    Range$0.11 - $0.35
    4 analysts
    Revenue Consensus
    $118M
    Range$83M - $164M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.19---
    Sep 26EST
    		-$0.08---
    Jun 26
    Reported Aug 4
    		$0.05$-0.02+350.00%Beat+162.5%
    Mar 26
    Reported May 13
    		$-0.02$-0.04+50.00%Beat+88.9%
    Dec 25
    Reported Mar 25
    		$-0.07$-0.08+20.29%Beat-66.0%
    Sep 25
    Reported Nov 13
    		$-1.06$-0.09-1077.78%Miss-1077.8%
    Jun 25
    Reported Aug 12
    		$-0.08$-0.08+0.00%Beat+20.0%
    Mar 25
    Reported May 14
    		$-0.18$-0.08-125.00%Miss-80.0%
    Dec 24
    Reported Mar 19
    		$-0.04$-0.06+33.33%Beat+69.2%
    Sep 24
    Reported Nov 14
    		$-0.09$-0.09+0.00%Beat-12.5%
    Jun 24
    Reported Aug 14
    		$-0.10$-0.09-11.11%Miss-25.0%
    Mar 24
    Reported May 14
    		$-0.10$-0.08-25.00%Miss+0.0%
    Dec 23
    Reported Mar 19
    		$-0.13$-0.08-62.50%Miss-18.2%
    Sep 23
    Reported Nov 9
    		$-0.08$-0.08+0.00%Beat-100.0%
    Jun 23
    Reported Aug 9
    		$-0.08$-0.10+20.00%Beat+0.0%
    Mar 23
    Reported May 10
    		$-0.10$-0.09-11.11%Miss+0.0%
    Dec 22
    Reported Mar 6
    		$-0.11$-0.12+8.33%Beat+15.4%
    Sep 22
    Reported Nov 9
    		$-0.04N/A+55.56%Beat+73.3%
    Jun 22
    Reported Aug 8
    		$-0.08$-0.14+42.86%Beat+20.0%
    Mar 22
    Reported May 9
    		$-0.10$-0.13+23.08%Beat+9.1%
    Dec 21
    Reported Mar 1
    		$-0.13$-0.12-8.33%Miss+43.5%
    Sep 21
    Reported Nov 8
    		$-0.15$-0.13-15.38%Miss+16.7%
    Jun 21
    Reported Aug 9
    		$-0.10$-0.12+16.67%Beat+61.5%
    Mar 21
    Reported May 10
    		$-0.11$-0.15+26.67%Beat+68.6%
    Dec 20
    Reported Mar 1
    		$-0.23$-0.17-35.29%Miss+17.9%
    Sep 20
    Reported Nov 9
    		$-0.18$-0.14-28.57%Miss+48.6%
    Jun 20
    Reported Aug 10
    		$-0.26$-0.13-100.00%Miss-4.0%
    Mar 20
    Reported May 6
    		$-0.35$-0.24-45.83%Miss+12.5%
    Dec 19
    Reported Mar 2
    		$-0.28$-0.29+3.45%Beat+89.2%
    Sep 19
    Reported Nov 12
    		$-0.35$-0.25-40.00%Miss+20.5%
    Jun 19
    Reported Aug 8
    		$-0.25$-0.29+13.79%Beat+51.0%
    Mar 19
    Reported May 9
    		$-0.40$-0.25-60.00%Miss-25.0%
    Dec 18
    Reported Feb 28
    		$-2.59$-0.34-661.76%Miss-2777.8%
    Sep 18
    Reported Nov 8
    		$-0.44$-0.23-91.30%Miss-25.7%
    Jun 18
    Reported Aug 13
    		$-0.51$-0.23-121.74%Miss-121.7%
    Mar 18
    Reported May 10
    		$-0.32$-0.24-33.33%Miss-28.0%
    Dec 17
    Reported Mar 1
    		$-0.09N/A+71.88%Beat+75.7%
    Sep 17
    Reported Nov 9
    		$-0.35$-0.15-133.33%Miss-
    Jun 17
    Reported Aug 9
    		$-0.23$-0.10-130.00%Miss-
    Mar 17
    Reported May 10
    		$-0.25$-0.22-13.64%Miss-
    Dec 16
    Reported Mar 1
    		$-0.37$-0.23-60.87%Miss-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-6.56EV/EBITDAN/A
    Price/FCF-22.29xFCF Yield-4.49%
    Profitability
    Profit Margin-184.00%Operating Margin41.20%
    ROE-837.00%ROIC-86.57%
    Financial Health
    Debt/Equity2.15xInterest CoverageN/A
    Current Ratio4.58xQuick Ratio3.89x
    Trading Statistics
    Beta0.92Avg Volume5.56M
    52-Week High$8.9852-Week Low$3.04

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.65
    SMA 20$7.77
    SMA 50$7.31
    SMA 200$5.16
    EMA 10$7.57
    EMA 20$7.59
    EMA 50$7.18
    EMA 200$5.48

    MACD

    Line: 0.06Signal: 0.17Hist: -0.12

    ADX

    ADX: 23.5+DI: 23.5-DI: 22.3

    Aroon & PSAR

    Aroon Up56.0
    Aroon DownN/A
    PSAR$8.39

    Bollinger Bands

    Upper Band$8.47
    Lower Band$7.06
    %B Position1813%(Upper)
    Band Width0.09

    RSI (14-Day)

    Neutral
    44.0

    Momentum Oscillators

    Stoch %K4.1
    Stoch %D13.3
    Williams %R-98.6
    ROC (10d)-12.4%
    Momentum-1.01
    CCI (20d)-134.0
    MFI (14d)41.4

    Volatility Measures

    ATR (14d)$0.41(5.7%)
    StdDev (20d)0.35
    Hist Vol57.9%(High)

    Volume Flow

    VWAP$7.30
    OBV279.9M
    AD Line-21.7M
    CMF (20d)-0.147

    Volume Metrics

    Avg Vol (20d)5.2M
    Vol Ratio0.8x
    VWMA (20d)$7.84

    Pivot Points

    R3$7.96
    R2$7.83
    R1$7.59
    Pivot Point$7.46
    S1$7.22
    S2$7.09
    S3$6.85

    Advanced Oscillators

    TSI3.97
    Ultimate Osc39.1
    KST77.64

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$54.98M$23.25M$3.71M$2.92M$856,000$1.34M$473,000$953,000$1.43M$1.06M$1.23M$1.38M
    Cost of Revenue$2.81M$2.56M$1.60M$1.03M$1.09M$1.10M$1.17M$1.01M$1.01M$1.07M$1.36M$1.54M
    Gross Profit$52.17M$20.69M$2.11M$1.89M$-236,000$241,000$-696,000$-56,000$420,000$-10,000$-130,000$-158,000
    Operating Expenses$29.53M$26.69M$24.64M$36.37M$31.53M$22.84M$28.54M$21.21M$60.54M$24.40M$34.09M$20.78M
    R&D$7.28M$5.64M$6.99M$12.38M$11.49M$10.48M$11.76M$11.37M$15.69M$14.25M$12.99M$11.58M
    SG&A$22.25M$21.05M$17.64M$23.99M$16.13M$12.36M$11.00M$9.84M$10.31M$10.15M$10.26M$9.20M
    Operating Income$22.64M$-5,994,000$-21,666,000$-34,481,000$-31,764,000$-22,596,000$-28,516,000$-21,262,000$-60,841,000$-24,410,000$-34,223,000$-20,937,000
    Interest Income$366,000$683,000$1.07M$534,000$696,000$918,000$208,000$283,000$319,000$608,000$920,000$856,000
    Interest Expense$2.95M$2.91M$1.84M$111.86M$0$1,000$15.06M$2.70M$2,000$0$0$0
    Income Before Tax$20.07M$-7,929,000$-23,503,000$-146,344,000$-26,639,000$-54,153,000$-43,581,000$-23,966,000$-60,481,000$0$-33,388,000$-19,801,000
    Income Tax Expense$0$0$0$0$3,000$0$-70,000$24,000$-1,689,000$-58,000$-277,000$-6,000
    Net Income$20.07M$-7,929,000$-23,503,000$-146,344,000$-26,642,000$-54,153,000$-19,727,000$-23,978,000$-58,792,000$-23,738,000$-33,056,000$-19,795,000
    EBITDA$23.91M$-4,629,000$-20,898,000$-145,419,000$-27,173,000$-55,147,000$-19,512,000$-23,735,000$-59,375,000$-23,175,000$-33,202,000$-19,579,000
    EBIT$22.66M$-5,704,000$-21,606,000$-145,976,000$-27,335,000$-55,070,000$-20,022,000$-24,247,000$-60,798,000$-24,373,000$-34,301,000$-20,656,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PGEN

    News

    Precigen Inc (PGEN) sentiment score, message volume, participation score and buzz level

    This article provides an overview of Precigen Inc (PGEN) stock's sentiment, message volume, and participation ratio on a social trading platform. It indicates whether users are bearish or bullish...

    Stocktwits•10/13/26•Neutral

    High Growth Tech Stocks To Watch In The US October 2026

    The U.S. market shows a positive trend with forecasted annual earnings growth of 18%, making high-growth tech stocks an attractive investment. This article highlights three key companies: Precigen (PGEN)...

    Simply Wall Street•10/9/26•Neutral

    Price to book forward of Precigen Inc – HAM:I5X

    This article provides the "Price to book forward" financial metric for Precigen Inc (HAM:I5X) on the Hamburg Stock Exchange. The data is presented for a specific period and includes value, change...

    TradingView•10/6/26•Neutral

    Why Did Precigen (PGEN) Stock Climb After Its Latest Update?

    Precigen (PGEN) stock recently climbed after its AdenoVerse immunotherapy platform received platform technology designation from the US FDA...

    Simply Wall Street•10/4/26•Bullish

    $Precigen (PGEN.US)$ DCA up

    A Moomoo user, Papacito, shared a post about Precigen (PGEN.US) with the caption "DCA up," indicating an increase in dollar-cost averaging for the stock. The post also includes a general market insight section on "Star...

    Moomoo•10/2/26•Bullish

    PGEN Valuation and Fair Value

    P/E
    -6.6x
    Forward P/E
    16.9x
    P/FCF
    -22.3x
    P/B
    58.9x
    See GNG's fair value

    PGEN Profitability: Margins, ROIC and FCF

    Gross margin
    90.6%
    Operating margin
    41.2%
    Net margin
    -184.0%
    ROIC
    -86.6%
    ROE
    -837.0%
    FCF margin
    -135.8%
    FCF yield
    -4.5%

    PGEN Competitors

    CompanyTicker
    Neogen CorporationNEOG
    TransMedics Group IncTMDX
    Aveanna Healthcare Holdings IncAVAH
    Nurix Therapeutics IncNRIX
    Privia Health Group IncPRVA
    Guardian Pharmacy Services, Inc.GRDN
    Dyne Therapeutics IncDYN
    Clover Health Investments CorpCLOV

    Sector: Healthcare

    PGEN Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    1
    Hold
    1
    Sell
    0
    Strong Sell
    0

    PGEN Bull Case vs Bear Case

    Bull case

    • PGEN grew quarterly revenue 6323.0% year over year.

    Bear case

    • PGEN has a -184.0% net profit margin.
    • PGEN has a debt-to-equity ratio of 2.2x.

    PGEN Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -93.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.08
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    PGEN Dividend

    Forward yield
    0.0%

    Frequently Asked Questions About PGEN

    Does PGEN pay dividends?

    Precigen Inc (PGEN) has a dividend payment track record. See the PGEN dividend history page for its current payment status, TTM yield, and recorded payments.

    What is PGEN's market cap?

    Precigen Inc (PGEN) has a market capitalization of $2.62B with a current stock price of $7.20.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In